Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ARL10 | Human | (+)-schisandrin B | multiple interactions | ISO | Arl10 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ARL10 mRNA] | CTD | PMID:31150632 | ARL10 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Arl10 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ARL10 mRNA | CTD | PMID:22206623 | ARL10 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of ARL10 mRNA | CTD | PMID:31614463 | ARL10 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Arl10 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of ARL10 gene | CTD | PMID:21212295 | ARL10 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Arl10 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARL10 mRNA | CTD | PMID:33387578 | ARL10 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Arl10 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ARL10 mRNA | CTD | PMID:21570461 | ARL10 | Human | 4,4'-diaminodiphenylmethane | increases expression | ISO | Arl10 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of ARL10 mRNA | CTD | PMID:18648102 | ARL10 | Human | 4,4'-sulfonyldiphenol | increases methylation | ISO | Arl10 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of ARL10 exon | CTD | PMID:33297965 | ARL10 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Arl10 (Mus musculus) | 6480464 | bisphenol S affects the methylation of ARL10 gene | CTD | PMID:31683443 | ARL10 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Arl10 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of ARL10 mRNA | CTD | PMID:22504374 | ARL10 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Arl10 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of ARL10 mRNA | CTD | PMID:24780913 | ARL10 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of ARL10 mRNA | CTD | PMID:32763439 | ARL10 | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of ARL10 mRNA | CTD | PMID:24449571 | ARL10 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of ARL10 mRNA | CTD | PMID:33212167 | ARL10 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of ARL10 promoter | CTD | PMID:27901495 | ARL10 | Human | bisphenol A | decreases expression | ISO | Arl10 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ARL10 mRNA | CTD | PMID:25181051 | ARL10 | Human | bisphenol A | increases expression | ISO | Arl10 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ARL10 mRNA | CTD | PMID:30816183 and PMID:32528016 | ARL10 | Human | chloroprene | increases expression | ISO | Arl10 (Rattus norvegicus) | 6480464 | Chloroprene results in increased expression of ARL10 mRNA | CTD | PMID:23125180 | ARL10 | Human | choline | multiple interactions | ISO | Arl10 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARL10 gene | CTD | PMID:20938992 | ARL10 | Human | copper atom | multiple interactions | ISO | Arl10 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ARL10 mRNA | CTD | PMID:15467011 | ARL10 | Human | copper(0) | multiple interactions | ISO | Arl10 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ARL10 mRNA | CTD | PMID:15467011 | ARL10 | Human | crocidolite asbestos | increases expression | ISO | Arl10 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in increased expression of ARL10 mRNA | CTD | PMID:19446018 | ARL10 | Human | decabromodiphenyl ether | decreases expression | ISO | Arl10 (Rattus norvegicus) | 6480464 | decabromobiphenyl ether results in decreased expression of ARL10 mRNA | CTD | PMID:23640034 | ARL10 | Human | dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of ARL10 mRNA | CTD | PMID:25596134 | ARL10 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL10 mRNA | CTD | PMID:27188386 | ARL10 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of ARL10 mRNA | CTD | PMID:29803840 | ARL10 | Human | endosulfan | increases expression | ISO | Arl10 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of ARL10 mRNA | CTD | PMID:29391264 | ARL10 | Human | epoxiconazole | increases expression | ISO | Arl10 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of ARL10 mRNA | CTD | PMID:35436446 | ARL10 | Human | folic acid | multiple interactions | ISO | Arl10 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARL10 gene | CTD | PMID:20938992 | ARL10 | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of ARL10 mRNA | CTD | PMID:27905399 | ARL10 | Human | gentamycin | decreases expression | ISO | Arl10 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ARL10 mRNA | CTD | PMID:33387578 | ARL10 | Human | L-methionine | multiple interactions | ISO | Arl10 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARL10 gene | CTD | PMID:20938992 | ARL10 | Human | lipopolysaccharide | multiple interactions | ISO | Arl10 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of ARL10 gene | CTD | PMID:21212295 | ARL10 | Human | methimazole | decreases expression | ISO | Arl10 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of ARL10 mRNA | CTD | PMID:22504374 | ARL10 | Human | nickel sulfate | decreases expression | EXP | | 6480464 | nickel sulfate results in decreased expression of ARL10 mRNA | CTD | PMID:22714537 | ARL10 | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of ARL10 mRNA | CTD | PMID:35430440 | ARL10 | Human | p-chloromercuribenzoic acid | decreases expression | EXP | | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of ARL10 mRNA | CTD | PMID:26272509 | ARL10 | Human | p-chloromercuribenzoic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL10 mRNA | CTD | PMID:27188386 | ARL10 | Human | paracetamol | affects expression | ISO | Arl10 (Mus musculus) | 6480464 | Acetaminophen affects the expression of ARL10 mRNA | CTD | PMID:17562736 | ARL10 | Human | paracetamol | decreases expression | ISO | Arl10 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of ARL10 mRNA | CTD | PMID:33387578 | ARL10 | Human | pirinixic acid | decreases expression | ISO | Arl10 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of ARL10 mRNA | CTD | PMID:17950772 | ARL10 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL10 mRNA | CTD | PMID:27188386 | ARL10 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of ARL10 mRNA | CTD | PMID:22714537 | ARL10 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of ARL10 mRNA | CTD | PMID:31533062 | ARL10 | Human | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of ARL10 mRNA | CTD | PMID:33359661 | ARL10 | Human | tetrachloromethane | increases expression | ISO | Arl10 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of ARL10 mRNA | CTD | PMID:31150632 | ARL10 | Human | tetrachloromethane | multiple interactions | ISO | Arl10 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ARL10 mRNA] | CTD | PMID:31150632 | ARL10 | Human | thioacetamide | increases expression | ISO | Arl10 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of ARL10 mRNA | CTD | PMID:23411599 | ARL10 | Human | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of ARL10 mRNA | CTD | PMID:30510588 | ARL10 | Human | triptonide | decreases expression | ISO | Arl10 (Mus musculus) | 6480464 | triptonide results in decreased expression of ARL10 mRNA | CTD | PMID:33045310 | ARL10 | Human | trovafloxacin | increases expression | ISO | Arl10 (Mus musculus) | 6480464 | trovafloxacin results in increased expression of ARL10 mRNA | CTD | PMID:35537566 | ARL10 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of ARL10 gene | CTD | PMID:29154799 | ARL10 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of ARL10 mRNA | CTD | PMID:23179753 | |